EMA Authorised: Zvogra (denosumab) — Stada Arzneimittel AG

View source ↗

Summary

The EMA authorised Zvogra (denosumab) for the treatment of giant cell tumor of bone and bone neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Neoplasms
• Giant Cell Tumor of Bone

Drugs mentioned

• Zvogra (denosumab)

Snippet

Status: Authorised. Therapeutic area: Giant Cell Tumor of Bone;Neoplasms, Bone Tissue. MAH: Stada Arzneimittel AG. Decision date: 18/12/2025